| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,404 |
4,786 |
$264K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,325 |
2,270 |
$134K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,015 |
935 |
$76K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,762 |
1,676 |
$59K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
435 |
419 |
$22K |
| 92552 |
|
1,224 |
1,184 |
$19K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,929 |
1,852 |
$18K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
225 |
221 |
$14K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
136 |
132 |
$9K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
422 |
414 |
$5K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
163 |
160 |
$5K |
| 99188 |
|
558 |
549 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
214 |
210 |
$5K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
59 |
57 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
45 |
44 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
87 |
85 |
$2K |
| 85018 |
|
1,016 |
994 |
$2K |
| 96127 |
|
347 |
338 |
$2K |
| 36416 |
|
755 |
736 |
$2K |
| 99173 |
|
1,377 |
1,341 |
$2K |
| 80061 |
Lipid panel |
113 |
111 |
$1K |
| 90686 |
|
496 |
488 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
157 |
153 |
$575.66 |
| 90461 |
|
13 |
12 |
$244.89 |
| 90651 |
|
33 |
32 |
$192.93 |
| 90734 |
|
42 |
41 |
$108.66 |
| 90715 |
|
13 |
13 |
$101.84 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
12 |
12 |
$70.28 |
| 96160 |
|
1,141 |
1,112 |
$69.96 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
360 |
329 |
$31.25 |
| X5622 |
|
685 |
672 |
$0.00 |
| 90648 |
|
13 |
13 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
32 |
15 |
$0.00 |
| 90670 |
|
13 |
13 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
15 |
14 |
$0.00 |